SEBIA
Manufacturing · France · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
27 Rue Léonard De Vinci, Lisses, Ile-de-...Phone Number
+33 169898080Website
www.sebia.comRevenue
$325.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About SEBIA
Sebia is a global leader in clinical electrophoresis technology, specializing in advanced equipment and reagents used for in-vitro diagnostic testing. The company’s innovative systems are designed to analyze proteins with precision, playing a crucial role in the screening and monitoring of a wide range of medical conditions. Sebia’s technology is particularly instrumental in oncology, aiding in the detection and management of diseases such as multiple myeloma, as well as in identifying metabolic disorders like diabetes and various hemoglobinopathies. With a commitment to improving patient outcomes, Sebia combines cutting-edge scientific expertise with reliable diagnostic solutions that support healthcare professionals worldwide. The company’s focus on innovation and quality ensures that its products remain at the forefront of clinical diagnostics, contributing significantly to early disease detection and ongoing patient care.Explore more
SEBIA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SEBIA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if SEBIA had a recent Job posting/layoffs
Check if SEBIA has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at SEBIA
Earning: See what the market has to say on SEBIA recently announced quarterly report
SEBIA, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once SEBIA has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if SEBIA is spiking on competitors!
Product Launch: Get notified when SEBIA launches new products
Recommended Actions
Reach out to Masked Content who joined SEBIA as Masked Content
Find 3 more new buyers
Compare Similar Companies to SEBIA
Compare insights from companies similar to SEBIA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SEBIA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SEBIA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SEBIA.
SEBIA Tech Stack
A closer look at the technologies used by SEBIA
Most Recent Scoops
Hiring Plans
SEBIA has more open roles in Engineering & Technical than it has had at any time in the past 6 months. Technologies mentioned include: SQL, and Amazon AWS.
Hiring Plans
Person-Based
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Facilities Relocation / Expansion
Facilities Relocation/Expansion
SEBIA News & Media
Sebia Receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devices
LISSES, France--(BUSINESS WIRE)-- #NBS--Sebia Receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devicesSebia Receives U.S. FDA Clearance for the FLC Kappa & Lambda Assays
LISSES, France--(BUSINESS WIRE)-- #FlC--Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the FLC Kappa & Lambda assays. These are the first EIA tests receiving 510(k) from the FDA for the quantitative detection of both kappa and lambda free light chains in humWater Street Completes Sale of Orgentec Diagnostika
CHICAGO, Sept. 8, 2021 /PRNewswire/ -- Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, announced today that it has completed the sale of specialty diagnostics company Orgentec Diagnostika to Sebia. Headquartered in Lisses, France,...Sebia Acquires Orgentec Diagnostika
The strategic acquisition reinforces Sebia's global leadership in specialty diagnostics LISSES, France, June 30, 2021 /PRNewswire/ -- Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, today announced the acquisition...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SEBIA
Sign Up For FreeTo access detailed company insights
Sebia is a global leader in clinical electrophoresis technology, specializing in advanced equipment and reagents used for in-vitro diagnostic testing. The company’s innovative systems are designed to analyze proteins with precision, playing a crucial role in the screening and monitoring of a wide range of medical conditions. Sebia’s technology is p... Read More
